DeepMed Research

Eske Corporation S.A.C.

🇵🇪Peru

Country: 🇵🇪Peru

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

Phase 3

Terminated

Conditions: Breast Cancer Stage IV
Breast Cancer, Stage IIIB
Breast Cancer Stage IIIA

Interventions: Drug: 1% Glycated Chitosan
Drug: Standard of Care
Device: Photothermal Laser
Drug: Placebo
Drug: Cyclophosphamide

First Posted Date: 2017-06-28

Last Posted Date: 2018-02-23

Lead Sponsor: Eske Corporation S.A.C

Target Recruit Count: 18

Registration Number: NCT03202446

Locations: 🇵🇪
Clinica Ricardo Palma, Lima, Peru
🇵🇪
Hospital Nacional Arzobispo Loayza, Lima, Peru
🇵🇪
Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru

and more 1 locations

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy